Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tesei

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of Translational Medicine|August 12, 2008
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell lineFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell linesLuca Ricotti, Anna Tesei, Franca De Paola, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 16, 2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesMarco Rosetti, Anna Tesei, Paola Ulivi, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 30, 2022
Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapySimona Micheletti, Patrizia Serra, Anna Tesei, et al.
Journal of Cellular Physiology|March 17, 2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell linesPaola Ulivi, Chiara Arienti, Dino Amadori, et al.
International Journal of Molecular Sciences|November 13, 2020
Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate CancerAlice Zamagni, Michele Zanoni, Michela Cortesi, et al.
Computational and Structural Biotechnology Journal|August 26, 2022
<i>CometAnalyser</i>: A user-friendly, open-source deep-learning microscopy tool for quantitative comet assay analysisAttila Beleon, Sara Pignatta, Chiara Arienti, et al.
Journal of Translational Medicine|February 5, 2005
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell linesAnna Tesei, Paola Ulivi, Francesco Fabbri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitroWainer Zoli, Luca Ricotti, Anna Tesei, et al.
Journal of Cellular Physiology|February 9, 2011
Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatusFrancesco Fabbri, Wainer Zoli, Silvia Carloni, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|August 12, 2008
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell lineFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell linesLuca Ricotti, Anna Tesei, Franca De Paola, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 16, 2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesMarco Rosetti, Anna Tesei, Paola Ulivi, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 30, 2022
Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapySimona Micheletti, Patrizia Serra, Anna Tesei, et al.
Journal of Cellular Physiology|March 17, 2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell linesPaola Ulivi, Chiara Arienti, Dino Amadori, et al.
International Journal of Molecular Sciences|November 13, 2020
Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate CancerAlice Zamagni, Michele Zanoni, Michela Cortesi, et al.
Computational and Structural Biotechnology Journal|August 26, 2022
<i>CometAnalyser</i>: A user-friendly, open-source deep-learning microscopy tool for quantitative comet assay analysisAttila Beleon, Sara Pignatta, Chiara Arienti, et al.
Journal of Translational Medicine|February 5, 2005
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell linesAnna Tesei, Paola Ulivi, Francesco Fabbri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitroWainer Zoli, Luca Ricotti, Anna Tesei, et al.
Journal of Cellular Physiology|February 9, 2011
Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatusFrancesco Fabbri, Wainer Zoli, Silvia Carloni, et al.
Pageof 10